🇺🇸 FDA
Patent

US 11275080

Methods for stratifying non-responders to therapies that block PD1/PDL1 axis

granted A61KA61K2039/505

Quick answer

US patent 11275080 (Methods for stratifying non-responders to therapies that block PD1/PDL1 axis) held by The Regents of the University of California expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505